Complete rectal prolapse

There are many treatment modalities in managing complete rectal prolapse [CRP] current study present simple technique of cauterization plication operation in the treatment of complete rectal prolapse. The study include 30 patients present with CRP their mean age [74.3 +/- 4.6], 19 females and 11 males. With the patient under- general anesthesia in litliotomy position the prolapsed rectum pulled outside the anal canal the mucosa was cauterized, the muscle layer was plicated by 2/0 dixon suture. Posterior levtorplasty were done in 10 adult patients when it is indicated. The postoperative follow up was 12-24 months. Six had postoperative mucosal prolapse and two had recurrence 5 months after operation. Fecal impaction, stricture and fistula formation were not encountered. The cauterization - plication operation is a simple and easy operation fix the treatment of CKP. It gave satisfactory results with minimal complications

helicobacter pylori eradication useful in patients taking NSAIDs?

To study the influence of H. pylori on therapeutic outcome in NSAIDs users, and the consequences of H. pylori eradication in NSAID users in controlled clinical trials. Two hundred six patients [n = 206; mean age 55 years; 70% female] with NSAlD-associated peptic ulceration tested for H. pylori infection, patients with appropriate symptoms who were confirmed to be infected with H. pylori, received eradication therapy, or omeprazole 20 mg plus placebos, those who were negative for H. pylori received omeprazole 20mg only for 1 week. All patients then, received omeprazole 20mg once daily for 3 weeks. Patients whose ulcers remained unhealed received 40mg omeprazole for further 4 weeks. Patients with no endoscopic evidence of ulceration at [4] or [8] weeks were then eligible to enter the assessment phase, for 6 months. Two hundred six patients with NSAIDs associated peptic ulceration had been tested for H. pylori. One hundred six patients being positive received eradication therapy, fifty patients being negative received omeperazole 20mg only, another fifty patients randomly selected include both positive and negative [control group] received 20mg omeperazole plus placebos, all groups continue on treatment for 1 week, then all groups continue for the next 3 weeks on omeperazole 20mg once daily. Endoscopy then reveals healing of the ulcers in 74% of the control group, 70% of the negative H. pylori group and only 42.3% of the positive H. pylori group, patients whose ulcers remained unhealed of all groups received 40mg omeprazole for further 4 weeks. Endoscopy then reveals healing of ulcers in 80%, 80%, 47.1% of the control, negative and positive group respectively. Hundred thirty of the healed ulcers of all groups entered the assessment phase for 6 months regarding remission and eradiation rates and the degree of gastric ulcer healing retardation. H. pylori eradication did not prevent ulcer recurrence during a six months assessment; indeed it retarded healing of gastric ulcers. The hypothesis that dyspepsia would be prevented by H. pylori eradication was not confirmed either